MorphoSys AG buy Mister_x
Summary
This prediction ended on 03.03.17 with a price of €60.00. The prediction had a final performance of 15.85%. Mister_x has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
MorphoSys AG | -1.476% | -1.476% | 262.181% | -16.395% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by Mister_x for this prediction
In the thread Morphosys AG diskutieren
Mister-x stimmt der Buy-Einschätzung von woelli zu
Mister-x stimmt am 21.02.2017 der Buy-Einschätzung von woelli mit dem Kursziel 59,69€ zu.
Überschrift: woelli stimmt dem Sentiment von 'Buy' zu